A Study on Remote Health Support for Patients With Heart Failure.

NCT07440472 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2026-02-27

No results posted yet for this study

Summary

This multicenter prospective observational feasibility study evaluates the implementation of the RAPHAEL model, a remote monitoring palliative care approach for patients with heart failure. The study aims to assess the feasibility, acceptability, usability, and implementation outcomes of integrating structured remote symptom monitoring and palliative care needs assessment into routine outpatient heart failure care.

Adult patients with heart failure and worsening symptoms and/or potential palliative care needs will complete a structured digital questionnaire during a 4-week follow-up period. Healthcare professionals will review reported needs and conduct follow-up contact according to usual clinical practice. No experimental drugs or devices are administered, and clinical management remains at the discretion of the treating team.

Primary outcomes focus on feasibility and implementation metrics, including participation rates, acceptability, usability, perceived burden, resource requirements, fidelity to the intervention model, training adoption, applicability, adaptation, and demand.

Conditions

Sponsors & Collaborators

  • Università degli Studi di Brescia

    collaborator OTHER
  • Linkoeping University

    collaborator OTHER_GOV
  • University College London Hospitals

    collaborator OTHER
  • European Association for Palliative Care (EAPC)

    collaborator UNKNOWN
  • Centre Hospitalier Universitaire Vaudois

    collaborator OTHER
  • University of Leeds

    collaborator OTHER
  • Maastricht University Medical Center

    collaborator OTHER
  • University of Humanistic Studies

    collaborator UNKNOWN
  • Althaia Xarxa Assistencial Universitària de Manresa

    collaborator OTHER
  • IRIS-CC

    collaborator UNKNOWN
  • University of Vic - Central University of Catalonia

    collaborator OTHER
  • University Hospital, Aachen

    collaborator OTHER
  • Wroclaw Medical University

    collaborator OTHER
  • UMC Utrecht

    collaborator OTHER
  • Vilnius University

    collaborator OTHER
  • Universitat Internacional de Catalunya

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-31
Primary Completion
2026-07-31
Completion
2026-07-31

Countries

  • Germany
  • Italy
  • Lithuania
  • Netherlands
  • Poland
  • Spain
  • Sweden
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07440472 on ClinicalTrials.gov